Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of graft cell dose on second transplantation from a haploidentical donor with post-transplantation cyclophosphamide for relapsed/refractory acute leukemia.
Nakaya Y, Nakamae H, Harada N, Okamura H, Sakatoku K, Ido K, Makuuchi Y, Kuno M, Takakuwa T, Hirose A, Nakamae M, Nishimoto M, Nakashima Y, Koh H, Hino M. Nakaya Y, et al. Among authors: koh h. Bone Marrow Transplant. 2023 Aug;58(8):947-949. doi: 10.1038/s41409-023-01986-6. Epub 2023 Apr 28. Bone Marrow Transplant. 2023. PMID: 37117265 No abstract available.
Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
Nakane T, Nakamae H, Kamoi H, Koh H, Takeoka Y, Sakamoto E, Kanashima H, Nakamae M, Ohta K, Terada Y, Koh KR, Yamane T, Hino M. Nakane T, et al. Among authors: koh kr, koh h. Bone Marrow Transplant. 2008 Jul;42(1):43-9. doi: 10.1038/bmt.2008.73. Epub 2008 Mar 17. Bone Marrow Transplant. 2008. PMID: 18347569
Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
Ohta K, Nishiki Kosaka S, Nakao Y, Kumura T, Hagihara K, Sakamoto E, Okamoto S, Hirose A, Aoyama Y, Yamamura R, Hayashi Y, Umemoto Y, Terada Y, Takeoka Y, Nakane T, Koh H, Hino M. Ohta K, et al. Among authors: koh h. Int J Hematol. 2009 Jun;89(5):649-55. doi: 10.1007/s12185-009-0316-3. Epub 2009 May 19. Int J Hematol. 2009. PMID: 19449195 Clinical Trial.
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma.
Terada Y, Nakamae H, Aimoto R, Kanashima H, Sakamoto E, Aimoto M, Inoue E, Koh H, Nakane T, Takeoka Y, Ohsawa M, Koh KR, Yamane T, Nakao Y, Ohta K, Mugitani A, Teshima H, Hino M. Terada Y, et al. Among authors: koh kr, koh h. J Exp Clin Cancer Res. 2009 Aug 19;28(1):116. doi: 10.1186/1756-9966-28-116. J Exp Clin Cancer Res. 2009. PMID: 19689822 Free PMC article.
[A modified myeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation, consisting of intravenous busulfan, cyclophosphamide and total lymphoid irradiation, in advanced leukemia].
Nakamae H, Terada Y, Nakane T, Koh H, Nakamae M, Aimoto R, Hirose A, Hayashi Y, Nishimoto M, Inoue E, Yoshimura T, Inoue A, Koh KR, Yamane T, Hino M. Nakamae H, et al. Among authors: koh kr, koh h. Gan To Kagaku Ryoho. 2010 Sep;37(9):1691-5. Gan To Kagaku Ryoho. 2010. PMID: 20841930 Japanese.
2,065 results